CVE-2021-1130
Summary
| CVE | CVE-2021-1130 |
|---|---|
| State | PUBLIC |
| Assigner | [email protected] |
| Source Priority | CVE Program / NVD first with legacy fallback |
| Published | 2021-01-13 22:15:00 UTC |
| Updated | 2023-11-07 03:27:00 UTC |
| Description | A vulnerability in the web-based management interface of Cisco DNA Center software could allow an authenticated, remote attacker to conduct a cross-site scripting (XSS) attack against a user of the interface of an affected device. The vulnerability exists because the web-based management interface does not properly validate user-supplied input. An attacker could exploit this vulnerability by persuading a user to click a crafted link. A successful exploit could allow the attacker to execute arbitrary script code in the context of the interface or access sensitive, browser-based information. To exploit this vulnerability, an attacker would need to have administrative credentials on the affected device. |
Risk And Classification
Problem Types: CWE-79
NVD Known Affected Configurations (CPE 2.3)
| Type | Vendor | Product | Version | Update | Edition | Language |
|---|---|---|---|---|---|---|
| Application | Cisco | Dna Center | All | All | All | All |
| Application | Cisco | Dna Center | All | All | All | All |
References
| Reference | Source | Link | Tags |
|---|---|---|---|
| Cisco DNA Center Cross-Site Scripting Vulnerability | CISCO | tools.cisco.com | Vendor Advisory |
| CVE Program record | CVE.ORG | www.cve.org | canonical |
| NVD vulnerability detail | NVD | nvd.nist.gov | canonical, analysis |
No vendor comments have been submitted for this CVE.
There are currently no legacy QID mappings associated with this CVE.